Nuvo Declared Winning Bidder to Acquire Commercial Products from Aralez

Nuvo Pharmaceuticals has been informed by Aralez Pharmaceuticals that Nuvo's previously announced acquisition of Aralez's Canadian business and the Vimovo royalty stream was the most favorable bid received and that Aralez will seek court approval for the transaction. The transaction must be approved by the Ontario Superior Court of Justice and the U.S. Bankruptcy Court for the Southern District of New York which oversee the respective pending proceedings involving Aralez and certain affiliates under Canada's Companies' Creditors Arrangement Act (the CCAA) and chapter 11 of the U.S. Bankruptcy Code. Subject to such court approvals and other customary closing conditions, closing is anticipated to occur prior to December 31, 2018.

On September 19, 2018, the company announced that it had entered into definitive, binding purchase agreements with Aralez to acquire a portfolio of revenue-generating products, as well as the associated personnel and infrastructure to continue the products' management and growth, subject to a competitive bidding and auction process approved by the U.S. and Ontario courts. Upon closing of the Transaction, Nuvo will pay Aralez US$110 million in cash (less the US$4.4 million deposit previously paid and subject to certain working capital adjustments), which Nuvo will satisfy through funding provided by certain funds managed by Deerfield Management, a global healthcare-specialized investor.

"We are excited about the prospect of gaining the benefit of the positive growth trend of the Aralez business in Canada," Jesse Ledger, Nuvo's President & CEO said. "We believe this transaction has the potential to create significant shareholder value by adding scale, diversification to our revenue streams and additional platforms for future growth."

-----------------------------------------------------------------------

Editor's Note:

To apply for becoming a contributor of En-CPhI.cn,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@ubmsinoexpo.com.